Phreesia (PHR) to Release Quarterly Earnings on Wednesday

Key Points

• Phreesia is expected to report Q2 2027 results after market close on September 2, 2026. Analysts forecast earnings of $0.11 per share and revenue of approximately $129.1 million.
• In its latest quarter, Phreesia reported EPS of $0.05, beating expectations of $0.02, while revenue rose 12.9% year over year to $130.94 million.
• PHR shares recently traded at $11.50, well below their 52-week high of $32.76. Analysts have a consensus “Hold” rating and an average price target of $16.65.

Phreesia (NYSE:PHR - Get Free Report) is expected to be announcing its Q2 2027 results after the market closes on Wednesday, September 2nd. Analysts expect the company to announce earnings of $0.11 per share and revenue of $129.0650 million for the quarter. Individuals are encouraged to explore the company's upcoming Q2 2027 earning report for the latest details on the call scheduled for Wednesday, September 2, 2026 at 5:00 PM ET.

Phreesia (NYSE:PHR - Get Free Report) last issued its earnings results on Wednesday, May 27th. The company reported $0.05 EPS for the quarter, beating analysts' consensus estimates of $0.02 by $0.03. Phreesia had a return on equity of 5.13% and a net margin of 1.85%.The firm had revenue of $130.94 million for the quarter, compared to the consensus estimate of $130.08 million. During the same quarter in the previous year, the company posted ($0.07) earnings per share. The business's quarterly revenue was up 12.9% compared to the same quarter last year. On average, analysts expect Phreesia to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Phreesia Stock Performance

Shares of PHR stock opened at $11.50 on Wednesday. Phreesia has a fifty-two week low of $7.77 and a fifty-two week high of $32.76. The stock's 50-day moving average is $10.88 and its two-hundred day moving average is $10.49. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.76 and a quick ratio of 1.76. The firm has a market cap of $710.75 million, a P/E ratio of 76.66 and a beta of 0.85.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Van ECK Associates Corp increased its position in Phreesia by 78.7% during the fourth quarter. Van ECK Associates Corp now owns 2,502 shares of the company's stock worth $42,000 after acquiring an additional 1,102 shares during the period. State of Wyoming bought a new stake in Phreesia in the 4th quarter valued at $99,000. Tower Research Capital LLC TRC grew its position in Phreesia by 332.5% in the 2nd quarter. Tower Research Capital LLC TRC now owns 5,610 shares of the company's stock worth $160,000 after purchasing an additional 4,313 shares during the last quarter. State of Tennessee Department of Treasury acquired a new stake in Phreesia in the 4th quarter worth $202,000. Finally, Creative Planning bought a new position in shares of Phreesia during the 3rd quarter worth about $218,000. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently commented on the company. Citigroup reissued a "market perform" rating on shares of Phreesia in a research note on Friday, May 29th. Weiss Ratings raised shares of Phreesia from a "sell (d)" rating to a "sell (d+)" rating in a research report on Monday, July 20th. DA Davidson restated a "buy" rating and set a $14.00 price target on shares of Phreesia in a research note on Thursday, May 28th. Truist Financial raised their price target on shares of Phreesia from $11.00 to $12.00 and gave the company a "hold" rating in a report on Thursday, May 28th. Finally, Canaccord Genuity Group reduced their price objective on shares of Phreesia from $22.00 to $16.00 and set a "buy" rating for the company in a research note on Thursday, May 28th. Nine investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $16.65.

About Phreesia

Phreesia, Inc NYSE: PHR is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company's cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source